პარკინსონის დაავადება

Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015 Oct;30(12):1591-601. აბსტრაქტი

Internation Parkinson and Movement Disorder Society. MDS position paper: diagnosis of Parkinson's disease. Mar 2023 [internet publication].სრული ტექსტი

Pringsheim T, Day GS, Smith DB, et al; Guideline Subcommittee of the AAN. Dopaminergic therapy for motor symptoms in early Parkinson disease practice guideline summary: a report of the AAN Guideline Subcommittee. Neurology. 2021 Nov 16;97(20):942-57.სრული ტექსტი  აბსტრაქტი

Seppi K, Ray Chaudhuri K, Coelho M, et al. Update on treatments for nonmotor symptoms of Parkinson's disease - an evidence-based medicine review. Mov Disord. 2019 Feb;34(2):180-98.სრული ტექსტი  აბსტრაქტი

Fox SH, Katzenschlager R, Lim SY, et al. International Parkinson and Movement Disorder Society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson's disease. Mov Disord. 2018 Aug;33(8):1248-66.სრული ტექსტი  აბსტრაქტი

Rughani A, Schwalb JM, Sidiropoulos C, et al. Congress of Neurological Surgeons systematic review and evidence-based guideline on subthalamic nucleus and globus pallidus internus deep brain stimulation for the treatment of patients with Parkinson's disease: executive summary. Neurosurgery. 2018 Jun 1;82(6):753-6.სრული ტექსტი  აბსტრაქტი

1. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015 Oct;30(12):1591-601. აბსტრაქტი

2. Quinn N, Crtichley P, Marsden CD. Young onset Parkinson's disease. Mov Disord. 1987;2:73-91. აბსტრაქტი

3. Bower JH, Maraganore DM, McDonnell SK, et al. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology. 1999 Apr 12;52(6):1214-20. აბსტრაქტი

4. Riccò M, Vezzosi L, Balzarini F, et al. Prevalence of Parkinson disease in Italy: a systematic review and meta-analysis. Acta Biomed. 2020 Sep 7;91(3):e2020088.სრული ტექსტი  აბსტრაქტი

5. GBD 2016 Parkinson's Disease Collaborators. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018 Nov;17(11):939-53.სრული ტექსტი  აბსტრაქტი

6. Pringsheim T, Jette N, Frolkis A, et al. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014 Nov;29(13):1583-90. აბსტრაქტი

7. Okubadejo NU, Bower JH, Rocca WA, et al. Parkinson's disease in Africa: a systematic review of epidemiologic and genetic studies. Mov Disord. 2006 Dec;21(12):2150-6. აბსტრაქტი

8. Ma CL, Su L, Xie JJ, et al. The prevalence and incidence of Parkinson's disease in China: a systematic review and meta-analysis. J Neural Transm (Vienna). 2014 Feb;121(2):123-34. აბსტრაქტი

9. Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003 Jun 1;157(11):1015-22.სრული ტექსტი  აბსტრაქტი

10. Wright Willis A, Evanoff BA, Lian M, et al. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 2010;34(3):143-51.სრული ტექსტი  აბსტრაქტი

11. Dahodwala N, Karlawish J, Siderowf A, et al. Delayed Parkinson's disease diagnosis among African-Americans: the role of reporting of disability. Neuroepidemiology. 2011;36(3):150-4.სრული ტექსტი  აბსტრაქტი

12. Marras C, Beck JC, Bower JH, et al. Prevalence of Parkinson's disease across North America. NPJ Parkinsons Dis. 2018 Jul 10;4:21.სრული ტექსტი  აბსტრაქტი

13. Hirsch L, Jette N, Frolkis A, et al. The incidence of Parkinson's disease: a systematic review and meta-analysis. Neuroepidemiology. 2016;46(4):292-300.სრული ტექსტი  აბსტრაქტი

14. Georgiev D, Hamberg K, Hariz M, et al. Gender differences in Parkinson's disease: a clinical perspective. Acta Neurol Scand. 2017 Dec;136(6):570-84. აბსტრაქტი

15. Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020 Feb 11;323(6):548-60. აბსტრაქტი

16. Nalls MA, Blauwendraat C, Vallerga CL, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019 Dec;18(12):1091-102. აბსტრაქტი

17. Bloem BR, Okun MS, Klein C. Parkinson's disease. Lancet. 2021 Jun 12;397(10291):2284-303. აბსტრაქტი

18. Blauwendraat C, Nalls MA, Singleton AB. The genetic architecture of Parkinson's disease. Lancet Neurol. 2020 Feb;19(2):170-8. აბსტრაქტი

19. Fang J, Hou B, Liu H, et al. Association between SNCA rs2736990 polymorphism and Parkinson's disease: a meta-analysis. Neurosci Lett. 2017 Sep 29;658:102-7. აბსტრაქტი

20. Liu X, Zhu R, Xiao T, et al. An updated analysis with 45,078 subjects confirms the association between SNCA rs11931074 and Parkinson's disease. Neurol Sci. 2018 Dec;39(12):2061-9. აბსტრაქტი

21. Zhao H, Kong Z. Relationship between LRRK2 R1628P polymorphism and Parkinson's disease in Asian populations. Oncotarget. 2016 Jul 26;7(30):46890-8.სრული ტექსტი  აბსტრაქტი

22. Funayama M, Nishioka K, Li Y, et al. Molecular genetics of Parkinson's disease: contributions and global trends. J Hum Genet. 2022 Jul 11 [Epub ahead of print].სრული ტექსტი  აბსტრაქტი

23. Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med. 2009 Oct 22;361(17):1651-61.სრული ტექსტი  აბსტრაქტი

24. Neumann J, Bras J, Deas E, et al. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain. 009 Jul;132(Pt 7):1783-94.სრული ტექსტი  აბსტრაქტი

25. Blauwendraat C, Reed X, Krohn L, et al. Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia. Brain. 2020 Jan 1;143(1):234-48.სრული ტექსტი  აბსტრაქტი

26. He T, Wang J, Wang X, et al. Association between PARK16 and Parkinson's disease: a meta-analysis. Neurosci Lett. 2017 Aug 12;657:179-88. აბსტრაქტი

27. Liu L, Zhang L, Guo L, et al. MTHFR C677T and A1298C polymorphisms may contribute to the risk of Parkinson's disease: a meta-analysis of 19 studies. Neurosci Lett. 2017 Oct 31;662:339-45. აბსტრაქტი

28. Fagan ES, Pihlstrøm L. Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature. Eur J Neurol. 2017 Apr;24(4):561-e20. აბსტრაქტი

29. Sayad M, Zouambia M, Chaouch M, et al. Greater improvement in LRRK2 G2019S patients undergoing subthalamic nucleus deep brain stimulation compared to non-mutation carriers. BMC Neurosci. 2016 Feb 1;17:6.სრული ტექსტი  აბსტრაქტი

30. Langston JW. The MPTP story. J Parkinsons Dis. 2017;7(s1):S11-9.სრული ტექსტი  აბსტრაქტი

31. Bjorklund G, Stejskal V, Urbina MA, et al. Metals and Parkinson's disease: mechanisms and biochemical processes. Curr Med Chem. 2018;25(19):2198-214. აბსტრაქტი

32. Oueslati A, Ximerakis M, Vekrellis K. Protein transmission, seeding and degradation: key steps for alpha-synuclein prion-like propagation. Exp Neurobiol. 2014 Dec;23(4):324-36.სრული ტექსტი  აბსტრაქტი

33. Wichmann T, DeLong MR. Functional neuroanatomy of the basal ganglia in Parkinson's disease. Adv Neurol. 2003;91:9-18. აბსტრაქტი

34. Jankovic J, Ben-Arie L, Schwartz K, et al. Movement and reaction times and fine coordination tasks following pallidotomy. Mov Disord. 1999 Jan;14(1):57-62. აბსტრაქტი

35. Vingerhoets FJ, Schulzer M, Calne DB, et al. Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion? Ann Neurol. 1997 Jan;41(1):58-64. აბსტრაქტი

36. Dostrovsky JO, Hutchinson WD, Lozano AM. The globus pallidus, deep brain stimulation and Parkinson's disease. Neuroscientist. 2002 Jun;8(3):284-90. აბსტრაქტი

37. Tatton WG, Lee RG. Evidence for abnormal long-loop reflexes in rigid Parkinsonian patients. Brain Res. 1975 Dec 26;100(3):671-6. აბსტრაქტი

38. Horak FB, Nutt JG, Nashner LM. Postural inflexibility in parkinsonism subjects. J Neurol Sci. 1992 Aug;111(1):46-58. აბსტრაქტი

39. Hedreen JC. Tyrosine hydroxylase-immunoreactive elements in the human globus pallidus and subthalamic nucleus. J Comp Neurol. 1999 Jul 5;409(3):400-10. აბსტრაქტი

40. Koller W, Pahwa R, Busenbark K, et al. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol. 1997 Sep;42(3):292-9. აბსტრაქტი

41. Lee RG, Stein RB. Resetting of tremor by mechanical perturbations: a comparison of essential tremor and parkinsonian tremor. Ann Neurol. 1981 Dec;10(6):523-31. აბსტრაქტი

42. Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003 Mar-Apr;24(2):197-211. აბსტრაქტი

43. Braak H, de Vos RA, Bohl J, et al. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett. 2006 Mar 20;396(1):67-72. აბსტრაქტი

44. Bloch A, Probst A, Bissig H, et al. Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol. 2006 Jun;32(3):284-95. აბსტრაქტი

45. Kasten M, Hartmann C, Hampf J, et al. Genotype-phenotype relations for the Parkinson's disease genes Parkin, PINK1, DJ1: MDSGene systematic review. Mov Disord. 2018 May;33(5):730-41. აბსტრაქტი

46. Langston JW, Ballard P, Tetrud JW, et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983 Feb 25;219(4587):979-80. აბსტრაქტი

47. Mortimer JA, Borenstein AR, Nelson LM. Associations of welding and manganese exposure with Parkinson disease: review and meta-analysis. Neurology. 2012 Sep 11;79(11):1174-80.სრული ტექსტი  აბსტრაქტი

48. Du K, Liu MY, Pan YZ, et al. Association of circulating manganese levels with Parkinson's disease: a meta-analysis. Neurosci Lett. 2018 Feb 5;665:92-8. აბსტრაქტი

49. Botsford E, George J, Buckley EE. Parkinson's disease and metal storage disorders: a systematic review. Brain Sci. 2018 Oct 31;8(11):194.სრული ტექსტი  აბსტრაქტი

50. Marder K, Tang MX, Mejia H, et al. Risk of Parkinson's disease among first-degree relatives: a community-based study. Neurology. 1996 Jul;47(1):155-60. აბსტრაქტი

51. Nicoletti A, Vasta R, Mostile G, et al. Head trauma and Parkinson's disease: results from an Italian case-control study. Neurol Sci. 2017 Oct;38(10):1835-9. აბსტრაქტი

52. Jafari S, Etminan M, Aminzadeh F, et al. Head injury and risk of Parkinson disease: a systematic review and meta-analysis. Mov Disord. 2013 Aug;28(9):1222-9. აბსტრაქტი

53. Kenborg L, Rugbjerg K, Lee PC, et al. Head injury and risk for Parkinson disease: results from a Danish case-control study. Neurology. 2015 Mar 17;84(11):1098-103.სრული ტექსტი  აბსტრაქტი

54. Martino R, Candundo H, Lieshout PV, et al. Onset and progression factors in Parkinson's disease: a systematic review. Neurotoxicology. 2017 Jul;61:132-41. აბსტრაქტი

55. Priyadarshi A, Khuder SA, Schaub EA, et al. Environmental risk factors and Parkinson's disease: a metaanalysis. Environ Res. 2001 Jun;86(2):122-7. აბსტრაქტი

56. Schoenberg BS. Environmental risk factors for Parkinson's disease: the epidemiologic evidence. Can J Neurol Sci. 1987 Aug;14(3 suppl):407-13. აბსტრაქტი

57. Pezzoli G, Cereda E. Exposure to pesticides or solvents and risk of Parkinson disease. Neurology. 2013 May 28;80(22):2035-41. აბსტრაქტი

58. Yan D, Zhang Y, Liu L, et al. Pesticide exposure and risk of Parkinson's disease: dose-response meta-analysis of observational studies. Regul Toxicol Pharmacol. 2018 Jul;96:57-63. აბსტრაქტი

59. Tangamornsuksan W, Lohitnavy O, Sruamsiri R, et al. Paraquat exposure and Parkinson's disease: a systematic review and meta-analysis. Arch Environ Occup Health. 2019;74(5):225-38. აბსტრაქტი

60. Barbosa ER, Leiros da Costa MD, Bacheschi LA, et al. Parkinsonism after glycine-derivate exposure. Mov Disord. 2001 May;16(3):565-8. აბსტრაქტი

61. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee to Review the Health Effects in Vietnam Veterans of Exposure to Herbicides (Eleventh Biennial Update). Veterans and Agent Orange: update 11 (2018). Washington, DC: The National Academies Press; 2018.სრული ტექსტი  აბსტრაქტი

62. Schulte PA, Burnett CA, Boeniger MF, et al. Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991. Am J Public Health. 1996 Sep;86(9):1281-8.სრული ტექსტი  აბსტრაქტი

63. Frigerio R, Elbaz A, Sanft KR, et al. Education and occupations preceding Parkinson disease: a population-based case-control study. Neurology. 2005 Nov 22;65(10):1575-83. აბსტრაქტი

64. Valdés EG, Andel R, Sieurin J, et al. Occupational complexity and risk of Parkinson's disease. PLoS One. 2014;9(9):e106676.სრული ტექსტი  აბსტრაქტი

65. Sieurin J, Andel R, Tillander A, et al. Occupational stress and risk for Parkinson's disease: a nationwide cohort study. Mov Disord. 2018 Sep;33(9):1456-64.სრული ტექსტი  აბსტრაქტი

66. Pouchieu C, Piel C, Carles C, et al. Pesticide use in agriculture and Parkinson's disease in the AGRICAN cohort study. Int J Epidemiol. 2018 Feb 1;47(1):299-310.სრული ტექსტი  აბსტრაქტი

67. Internation Parkinson and Movement Disorder Society. MDS position paper: diagnosis of Parkinson's disease. Mar 2023 [internet publication].სრული ტექსტი

68. Pfeiffer RF. Non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S119-22. აბსტრაქტი

69. Postuma RB, Poewe W, Litvan I, et al. Validation of the MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2018 Oct;33(10):1601-8. აბსტრაქტი

70. Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017 Jul;18(7):435-50. აბსტრაქტი

71. Knudsen K, Krogh K, Østergaard K, et al. Constipation in Parkinson's disease: subjective symptoms, objective markers, and new perspectives. Mov Disord. 2017 Jan;32(1):94-105. აბსტრაქტი

72. Schrag A, Barone P, Brown RG, et al. Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord. 2007 Jun 15;22(8):1077-92.სრული ტექსტი  აბსტრაქტი

73. Lawton M, Hu MT, Baig F, et al. Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease. Parkinsonism Relat Disord. 2016 Dec;33:96-101.სრული ტექსტი  აბსტრაქტი

74. Nielsen T, Jensen MB, Stenager E, et al. The use of olfactory testing when diagnosing Parkinson's disease - a systematic review. Dan Med J. 2018 May;65(5):A5481. აბსტრაქტი

75. Ponsen MM, Stoffers D, Booij J, et al. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol. 2004 Aug;56(2):173-81. აბსტრაქტი

76. Kägi G, Bhatia KP, Tolosa E. The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):5-12. აბსტრაქტი

77. Kalra S, Grosset DG, Benamer HT. Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review. Mov Disord. 2010 Jan 30;25(2):149-56. აბსტრაქტი

78. Koros C, Simitsi AM, Prentakis A, et al. DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson's disease: Longitudinal data from the PPMI study. Parkinsonism Relat Disord. 2020 Aug;77:36-42. აბსტრაქტი

79. American College of Radiology​. ACR–ACNM–SNMMI practice parameter for the performance of dopamine transporter (DaT) single photon emission computed tomography (SPECT) imaging for movement disorders. 2022 [internet publication].სრული ტექსტი

80. Orimo S, Suzuki M, Inaba A, et al. 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2012 Jun;18(5):494-500. აბსტრაქტი

81. Braune S. The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clin Auton Res. 2001 Dec;11(6):351-5. აბსტრაქტი

82. Treglia G, Stefanelli A, Cason E, et al. Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis. Clin Neurol Neurosurg. 2011 Dec;113(10):823-9. აბსტრაქტი

83. Berardelli A, Wenning GK, Antonini A, et al. EFNS/MDS-ES/ENS recommendations for the diagnosis of Parkinson's disease. Eur J Neurol. 2013 Jan;20(1):16-34.სრული ტექსტი  აბსტრაქტი

84. Chang D, Nalls MA, Hallgrímsdóttir IB, et al. A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci. Nat Genet. 2017 Oct;49(10):1511-6.სრული ტექსტი  აბსტრაქტი

85. Kuzkina A, Schulmeyer L, Monoranu CM, et al. The aggregation state of α-synuclein deposits in dermal nerve fibers of patients with Parkinson's disease resembles that in the brain. Parkinsonism Relat Disord. 2019 Jul;64:66-72. აბსტრაქტი

86. Donadio V. Skin nerve α-synuclein deposits in Parkinson's disease and other synucleinopathies: a review. Clin Auton Res. 2019 Dec;29(6):577-85. აბსტრაქტი

87. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999 Jan;56(1):33-9. აბსტრაქტი

88. Bhatia KP, Bain P, Bajaj N, et al; Tremor Task Force of the International Parkinson and Movement Disorder Society. Consensus statement on the classification of tremors. From the Task Force on Tremor of the International Parkinson and Movement Disorder Society. Mov Disord. 2018 Jan;33(1):75-87.სრული ტექსტი  აბსტრაქტი

89. Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord. 1998;13 Suppl 3:2-23. აბსტრაქტი

90. Reiter E, Mueller C, Pinter B, et al. Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative parkinsonism. Mov Disord. 2015 Jul;30(8):1068-76. აბსტრაქტი

91. Cho SJ, Bae YJ, Kim JM, et al. Iron-sensitive magnetic resonance imaging in Parkinson's disease: a systematic review and meta-analysis. J Neurol. 2021 Dec;268(12):4721-36. აბსტრაქტი

92. Höglinger GU, Respondek G, Stamelou M, et al; Movement Disorder Society-endorsed PSP Study Group. Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society criteria. Mov Disord. 2017 Jun;32(6):853-64.სრული ტექსტი  აბსტრაქტი

93. Wenning GK, Ben-Shlomo Y, Hughes A, et al. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):434-40.სრული ტექსტი  აბსტრაქტი

94. Zupancic M, Mahajan A, Handa K. Dementia with Lewy bodies: diagnosis and management for primary care providers. Prim Care Companion CNS Disord. 2011;13(5):PCC.11r01190.სრული ტექსტი  აბსტრაქტი

95. McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017 Jul 4;89(1):88-100.სრული ტექსტი  აბსტრაქტი

96. Goetz CG, Tilley BC, Shaftman SR, et al; Movement Disorder Society UPDRS Revision Task Force. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008 Nov 15;23(15):2129-70.სრული ტექსტი  აბსტრაქტი

97. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4.სრული ტექსტი  აბსტრაქტი

98. García-Ramos R, Santos-García D, Alonso-Cánovas A, et al. Management of Parkinson's disease and other movement disorders in women of childbearing age: part 1 [in Spanish]. Neurologia (Engl Ed). 2021 Mar;36(2):149-58. აბსტრაქტი

99. Pringsheim T, Day GS, Smith DB, et al; Guideline Subcommittee of the AAN. Dopaminergic therapy for motor symptoms in early Parkinson disease practice guideline summary: a report of the AAN Guideline Subcommittee. Neurology. 2021 Nov 16;97(20):942-57.სრული ტექსტი  აბსტრაქტი

100. National Institute for Health and Care Excellence. Parkinson's disease in adults. Jul 2017 [internet publication].სრული ტექსტი

101. Luis-Martínez R, Monje MHG, Antonini A, et al. Technology-enabled care: integrating multidisciplinary care in Parkinson's disease through digital technology. Front Neurol. 2020 Oct 30;11:575975.სრული ტექსტი  აბსტრაქტი

102. Lima LO, Scianni A, Rodrigues-de-Paula F. Progressive resistance exercise improves strength and physical performance in people with mild to moderate Parkinson's disease: a systematic review. J Physiother. 2013 Mar;59(1):7-13. აბსტრაქტი

103. Tomlinson CL, Patel S, Meek C, et al. Physiotherapy versus placebo or no intervention in Parkinson's disease. Cochrane Database Syst Rev. 2013 Sep 10;(9):CD002817.სრული ტექსტი  აბსტრაქტი

104. Schindler A, Pizzorni N, Cereda E, et al. Consensus on the treatment of dysphagia in Parkinson's disease. J Neurol Sci. 2021 Nov 15;430:120008.სრული ტექსტი  აბსტრაქტი

105. Welsby E, Berrigan S, Laver K. Effectiveness of occupational therapy intervention for people with Parkinson's disease: systematic review. Aust Occup Ther J. 2019 Dec;66(6):731-8. აბსტრაქტი

106. Allen NE, Sherrington C, Paul SS, et al. Balance and falls in Parkinson's disease: a meta-analysis of the effect of exercise and motor training. Mov Disord. 2011 Aug 1;26(9):1605-15. აბსტრაქტი

107. Rao AK. Enabling functional independence in Parkinson's disease: update on occupational therapy intervention. Mov Disord. 2010;25(suppl 1):S146-51. აბსტრაქტი

108. Corcos DM, Robichaud JA, David FJ, et al. A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease. Mov Disord. 2013 Aug;28(9):1230-40.სრული ტექსტი  აბსტრაქტი

109. Osborne JA, Botkin R, Colon-Semenza C, et al. Physical therapist management of Parkinson disease: a clinical practice guideline from the American Physical Therapy Association. Phys Ther. 2022 Apr 1;102(4):pzab302.სრული ტექსტი  აბსტრაქტი

110. Radder DLM, Lígia Silva de Lima A, Domingos J, et al. Physiotherapy in Parkinson's disease: a meta-analysis of present treatment modalities. Neurorehabil Neural Repair. 2020 Oct;34(10):871-80.სრული ტექსტი  აბსტრაქტი

111. Fidan O, Seyyar GK, Aras B, et al. The effect of Tai Chi and Qigong on health-related quality of life in Parkinson's disease: a systematic review and meta-analysis of systematic reviews. Int J Rehabil Res. 2019 Sep;42(3):196-204. აბსტრაქტი

112. Bega D, Gonzalez-Latapi P, Zadikoff C, et al. A review of the clinical evidence for complementary and alternative therapies in Parkinson's disease. Curr Treat Options Neurol. 2014 Oct;16(10):314. აბსტრაქტი

113. Zhou Z, Zhou R, Wei W, et al. Effects of music-based movement therapy on motor function, balance, gait, mental health, and quality of life for patients with Parkinson's disease: a systematic review and meta-analysis. Clin Rehabil. 2021 Jul;35(7):937-51. აბსტრაქტი

114. Dos Santos Delabary M, Komeroski IG, Monteiro EP, et al. Effects of dance practice on functional mobility, motor symptoms and quality of life in people with Parkinson's disease: a systematic review with meta-analysis. Aging Clin Exp Res. 2018 Jul;30(7):727-35. აბსტრაქტი

115. García-Casares N, Martín-Colom JE, García-Arnés JA. Music therapy in Parkinson's disease. J Am Med Dir Assoc. 2018 Dec;19(12):1054-62. აბსტრაქტი

116. Cugusi L, Manca A, Bergamin M, et al. Aquatic exercise improves motor impairments in people with Parkinson's disease, with similar or greater benefits than land-based exercise: a systematic review. J Physiother. 2019 Apr;65(2):65-74.სრული ტექსტი  აბსტრაქტი

117. Gomes Neto M, Pontes SS, Almeida LO, et al. Effects of water-based exercise on functioning and quality of life in people with Parkinson's disease: a systematic review and meta-analysis. Clin Rehabil. 2020 Dec;34(12):1425-35. აბსტრაქტი

118. Ni M, Hazzard JB, Signorile JF, et al. Exercise guidelines for gait function in Parkinson's disease: a systematic review and meta-analysis. Neurorehabil Neural Repair. 2018 Oct;32(10):872-86.სრული ტექსტი  აბსტრაქტი

119. McDonnell MN, Rischbieth B, Schammer TT, et al. Lee Silverman Voice Treatment (LSVT)-BIG to improve motor function in people with Parkinson's disease: a systematic review and meta-analysis. Clin Rehabil. 2018 May;32(5):607-18. აბსტრაქტი

120. Peterka M, Odorfer T, Schwab M, et al. LSVT-BIG therapy in Parkinson's disease: physiological evidence for proprioceptive recalibration. BMC Neurol. 2020 Jul 11;20(1):276.სრული ტექსტი  აბსტრაქტი

121. Rutz DG, Benninger DH. Physical therapy for freezing of gait and gait impairments in Parkinson disease: a systematic review. PM R. 2020 Nov;12(11):1140-56. აბსტრაქტი

122. Kashif M, Ahmad A, Bandpei MAM, et al. Combined effects of virtual reality techniques and motor imagery on balance, motor function and activities of daily living in patients with Parkinson's disease: a randomized controlled trial. BMC Geriatr. 2022 Apr 30;22(1):381.სრული ტექსტი  აბსტრაქტი

123. Lu Y, Ge Y, Chen W, et al. The effectiveness of virtual reality for rehabilitation of Parkinson disease: an overview of systematic reviews with meta-analyses. Syst Rev. 2022 Mar 19;11(1):50.სრული ტექსტი  აბსტრაქტი

124. Lina C, Guoen C, Huidan W, et al. The effect of virtual reality on the ability to perform activities of daily living, balance during gait, and motor function in Parkinson disease patients: a systematic review and meta-analysis. Am J Phys Med Rehabil. 2020 Oct;99(10):917-24. აბსტრაქტი

125. Seppi K, Ray Chaudhuri K, Coelho M, et al. Update on treatments for nonmotor symptoms of Parkinson's disease - an evidence-based medicine review. Mov Disord. 2019 Feb;34(2):180-98.სრული ტექსტი  აბსტრაქტი

126. Baillon S, Dennis M, Lo N, et al. Screening for depression in Parkinson's disease: the performance of two screening questions. Age Ageing. 2014 Mar;43(2):200-5.სრული ტექსტი  აბსტრაქტი

127. Broen MP, Narayen NE, Kuijf ML, et al. Prevalence of anxiety in Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2016 Aug;31(8):1125-33. აბსტრაქტი

128. Hong CT, Tan S, Huang TW. Psychotherapy for the treatment of anxiety and depression in patients with Parkinson disease: a meta-analysis of randomized controlled trials. J Am Med Dir Assoc. 2021 Nov;22(11):2289-95.e2. აბსტრაქტი

129. Zečević I. Clinical practice guidelines based on evidence for cognitive-behavioural therapy in Parkinson's disease comorbidities: a literature review. Clin Psychol Psychother. 2020 Jul;27(4):504-14. აბსტრაქტი

130. Lawrence BJ, Gasson N, Bucks RS, et al. Cognitive training and noninvasive brain stimulation for cognition in Parkinson's disease: a meta-analysis. Neurorehabil Neural Repair. 2017 Jul;31(7):597-608. აბსტრაქტი

131. Alzahrani H, Venneri A. Cognitive rehabilitation in Parkinson's disease: a systematic review. J Parkinsons Dis. 2018;8(2):233-45. აბსტრაქტი

132. da Silva FC, Iop RDR, de Oliveira LC, et al. Effects of physical exercise programs on cognitive function in Parkinson's disease patients: a systematic review of randomized controlled trials of the last 10 years. PLoS One. 2018 Feb 27;13(2):e0193113.სრული ტექსტი  აბსტრაქტი

133. Negida A, Menshawy A, El Ashal G, et al. Coenzyme Q10 for patients with Parkinson's disease: a systematic review and meta-analysis. CNS Neurol Disord Drug Targets. 2016;15(1):45-53. აბსტრაქტი

134. Zhou Z, Zhou R, Zhang Z, et al. The association between vitamin D status, vitamin D supplementation, sunlight exposure, and Parkinson's disease: a systematic review and meta-analysis. Med Sci Monit. 2019 Jan 23;25:666-74.სრული ტექსტი  აბსტრაქტი

135. Luthra NS, Kim S, Zhang Y, et al. Characterization of vitamin D supplementation and clinical outcomes in a large cohort of early Parkinson's disease. J Clin Mov Disord. 2018 Oct 31;5:7.სრული ტექსტი  აბსტრაქტი

136. Chang MC, Kwak SG, Kwak S. Effect of dietary vitamins C and E on the risk of Parkinson's disease: a meta-analysis. Clin Nutr. 2021 Jun;40(6):3922-30. აბსტრაქტი

137. Fox SH, Katzenschlager R, Lim SY, et al. International Parkinson and Movement Disorder Society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson's disease. Mov Disord. 2018 Aug;33(8):1248-66.სრული ტექსტი  აბსტრაქტი

138. Thanvi B, Treadwell S. Drug induced parkinsonism: a common cause of parkinsonism in older people. Postgrad Med J. 2009 Jun;85(1004):322-6. აბსტრაქტი

139. Chen F, Jin L, Nie Z. Safety and efficacy of rotigotine for treating Parkinson's disease: a meta-analysis of randomised controlled trials. J Pharm Pharm Sci. 2017;20(0):285-94. აბსტრაქტი

140. Zhu J, Chen M. The effect and safety of ropinirole in the treatment of Parkinson disease: a systematic review and meta-analysis. Medicine (Baltimore). 2021 Nov 19;100(46):e27653.სრული ტექსტი  აბსტრაქტი

141. Binde CD, Tvete IF, Gåsemyr JI, et al. Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson's disease: a multiple treatment comparison meta-analysis. Eur J Clin Pharmacol. 2020 Dec;76(12):1731-43.სრული ტექსტი  აბსტრაქტი

142. Stocchi F, Antonini A, Berg D, et al. Safinamide in the treatment pathway of Parkinson's disease: a European Delphi Consensus. NPJ Parkinsons Dis. 2022 Feb 21;8(1):17.სრული ტექსტი  აბსტრაქტი

143. Rascol O, Hauser RA, Stocchi F, et al. Long-term effects of rasagiline and the natural history of treated Parkinson's disease. Mov Disord. 2016 Oct;31(10):1489-96. აბსტრაქტი

144. Stowe R, Ives N, Clarke CE, et al. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson's disease patients with motor complications. Cochrane Database Syst Rev. 2010 Jul 7;(7):CD007166.სრული ტექსტი  აბსტრაქტი

145. Li J, Lou Z, Liu X, et al. Efficacy and safety of adjuvant treatment with entacapone in advanced Parkinson's disease with motor fluctuation: a systematic meta-analysis. Eur Neurol. 2017;78(3-4):143-53.სრული ტექსტი  აბსტრაქტი

146. Katsaiti I, Nixon J. Are there benefits in adding catechol-o methyltransferase inhibitors in the pharmacotherapy of Parkinson's disease patients? A systematic review. J Parkinsons Dis. 2018;8(2):217-31. აბსტრაქტი

147. Ferreira JJ, Lees A, Rocha JF, et al. Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial. Lancet Neurol. 2016 Feb;15(2):154-65. აბსტრაქტი

148. Lees AJ, Ferreira J, Rascol O, et al. Opicapone as adjunct to levodopa therapy in patients with Parkinson disease and motor fluctuations: a randomized clinical trial. JAMA Neurol. 2017 Feb 1;74(2):197-206.სრული ტექსტი  აბსტრაქტი

149. Wang Y, Jiang DQ, Lu CS, et al. Efficacy and safety of combination therapy with pramipexole and levodopa vs levodopa monotherapy in patients with Parkinson disease: a systematic review and meta-analysis. Medicine (Baltimore). 2021 Nov 5;100(44):e27511.სრული ტექსტი  აბსტრაქტი

150. Giossi R, Carrara F, Mazzari M, et al. Overall efficacy and safety of safinamide in Parkinson's disease: a systematic review and a meta-analysis. Clin Drug Investig. 2021 Apr;41(4):321-39.სრული ტექსტი  აბსტრაქტი

151. Jiang DQ, Wang HK, Wang Y, et al. Rasagiline combined with levodopa therapy versus levodopa monotherapy for patients with Parkinson's disease: a systematic review. Neurol Sci. 2020 Jan;41(1):101-9. აბსტრაქტი

152. Jiang DQ, Li MX, Jiang LL, et al. Comparison of selegiline and levodopa combination therapy versus levodopa monotherapy in the treatment of Parkinson's disease: a meta-analysis. Aging Clin Exp Res. 2020 May;32(5):769-79. აბსტრაქტი

153. Hauser RA, Hsu A, Kell S, et al. Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial. Lancet Neurol. 2013 Apr;12(4):346-56. აბსტრაქტი

154. LeWitt PA, Huff FJ, Hauser RA, et al. Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease. Mov Disord. 2014 Jan;29(1):75-82. აბსტრაქტი

155. Stocchi F, Hsu A, Khanna S, et al. Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients. Parkinsonism Relat Disord. 2014 Dec;20(12):1335-40.სრული ტექსტი  აბსტრაქტი

156. Paton DM. Istradefylline: adenosine A2A receptor antagonist to reduce "OFF" time in Parkinson's disease. Drugs Today (Barc). 2020 Feb;56(2):125-34. აბსტრაქტი

157. Isaacson SH, Betté S, Pahwa R. Istradefylline for OFF episodes in Parkinson's disease: a US perspective of common clinical scenarios. Degener Neurol Neuromuscul Dis. 2022 Jul 23;12:97-109.სრული ტექსტი  აბსტრაქტი

158. Sako W, Murakami N, Motohama K, et al. The effect of istradefylline for Parkinson's disease: a meta-analysis. Sci Rep. 2017 Dec 21;7(1):18018.სრული ტექსტი  აბსტრაქტი

159. Takahashi M, Fujita M, Asai N, et al. Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan. Expert Opin Pharmacother. 2018 Oct;19(15):1635-42.სრული ტექსტი  აბსტრაქტი

160. Lang AE, Houeto JL, Krack P, et al. Deep brain stimulation: preoperative issues. Mov Disord. 2006 Jun;21 (suppl 14):S171-96. აბსტრაქტი

161. Peng L, Fu J, Ming Y, et al. The long-term efficacy of STN vs GPi deep brain stimulation for Parkinson disease: a meta-analysis. Medicine (Baltimore). 2018 Aug;97(35):e12153.სრული ტექსტი  აბსტრაქტი

162. Antonini A, Odin P, Pahwa R, et al. The long-term impact of levodopa/carbidopa intestinal gel on 'off'-time in patients with advanced Parkinson's disease: a systematic review. Adv Ther. 2021 Jun;38(6):2854-90.სრული ტექსტი  აბსტრაქტი

163. Deuschl G, Antonini A, Costa J, et al. European Academy of Neurology/Movement Disorder Society - European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies. Eur J Neurol. 2022 Sep;29(9):2580-95.სრული ტექსტი  აბსტრაქტი

164. Katzenschlager R, Poewe W, Rascol O, et al. Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2018 Sep;17(9):749-59. აბსტრაქტი

165. Olanow CW, Factor SA, Espay AJ, et al; CTH-300 Study investigators. Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study. Lancet Neurol. 2020 Feb;19(2):135-44. აბსტრაქტი

166. Hui JS, Fox SH, Neeson W, et al; CTH-300 Study Investigators. Open-label titration of apomorphine sublingual film in patients with Parkinson's disease and "OFF" episodes. Parkinsonism Relat Disord. 2020 Oct;79:110-6.სრული ტექსტი  აბსტრაქტი

167. LeWitt PA, Hauser RA, Pahwa R, et al. Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Neurol. 2019 Feb;18(2):145-54. აბსტრაქტი

168. Rughani A, Schwalb JM, Sidiropoulos C, et al. Congress of Neurological Surgeons systematic review and evidence-based guideline on subthalamic nucleus and globus pallidus internus deep brain stimulation for the treatment of patients with Parkinson's disease: executive summary. Neurosurgery. 2018 Jun 1;82(6):753-6.სრული ტექსტი  აბსტრაქტი

169. Suarez-Cedeno G, Suescun J, Schiess MC. Earlier intervention with deep brain stimulation for Parkinson's disease. Parkinsons Dis. 2017;2017:9358153.სრული ტექსტი  აბსტრაქტი

170. Mansouri A, Taslimi S, Badhiwala JH, et al. Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up. J Neurosurg. 2018 Apr;128(4):1199-213.სრული ტექსტი  აბსტრაქტი

171. Wong JK, Cauraugh JH, Ho KWD, et al. STN vs. GPi deep brain stimulation for tremor suppression in Parkinson disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2019 Jan;58:56-62.სრული ტექსტი  აბსტრაქტი

172. Zhang J, Li J, Chen F, et al. STN versus GPi deep brain stimulation for dyskinesia improvement in advanced Parkinson's disease: a meta-analysis of randomized controlled trials. Clin Neurol Neurosurg. 2021 Feb;201:106450. აბსტრაქტი

173. Taylor LP, Besbris JM, Graf WD, et al. Clinical guidance in neuropalliative care: an AAN position statement. Neurology. 2022 Mar 8;98(10):409-16.სრული ტექსტი  აბსტრაქტი

174. European Medicines Agency. CMDh confirms recommendations on restricting use of domperidone-containing medicines. Apr 2014 [internet publication].სრული ტექსტი

175. Mulvaney CA, Duarte GS, Handley J, et al. GLP-1 receptor agonists for Parkinson's disease. Cochrane Database Syst Rev. 2020 Jul 23;(7):CD012990.სრული ტექსტი  აბსტრაქტი

176. Xie YJ, Gao Q, He CQ, et al. Effect of repetitive transcranial magnetic stimulation on gait and freezing of gait in Parkinson disease: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2020 Jan;101(1):130-40. აბსტრაქტი

177. Nascimento LR, do Carmo WA, de Oliveira GP, et al. Transcranial direct current stimulation provides no clinically important benefits over walking training for improving walking in Parkinson's disease: a systematic review. J Physiother. 2021 Jul;67(3):190-6.სრული ტექსტი  აბსტრაქტი

178. Chen J, He P, Zhang Y, et al. Non-pharmacological treatment for Parkinson disease patients with depression: a meta-analysis of repetitive transcranial magnetic stimulation and cognitive-behavioral treatment. Int J Neurosci. 2021 Apr;131(4):411-24. აბსტრაქტი

179. Nardone R, Versace V, Brigo F, et al. Transcranial magnetic stimulation and gait disturbances in Parkinson's disease: a systematic review. Neurophysiol Clin. 2020 Jul;50(3):213-25. აბსტრაქტი

180. Lench DH, DeVries W, Kearney-Ramos TE, et al. Paired inhibitory stimulation and gait training modulates supplemental motor area connectivity in freezing of gait. Parkinsonism Relat Disord. 2021 Jul;88:28-33.სრული ტექსტი  აბსტრაქტი

181. Moore SF, Guzman NV, Mason SL, et al. Which patients with Parkinson's disease participate in clinical trials? One centre's experiences with a new cell based therapy trial (TRANSEURO). J Parkinsons Dis. 2014;4(4):671-6. აბსტრაქტი

182. ClinicalTrials.gov. TRANSEURO open label transplant study in Parkinson's disease (TRANSEURO). NCT01898390. Apr 2019 [internet publication].სრული ტექსტი

183. ClinicalTrials.gov. A study to evaluate the safety of neural stem cells in patients with Parkinson's disease. NCT02452723. Apr 2019 [internet publication].სრული ტექსტი

184. Barker RA; TRANSEURO consortium. Designing stem-cell-based dopamine cell replacement trials for Parkinson's disease. Nat Med. 2019 Jul;25(7):1045-53. აბსტრაქტი

185. Richardson RM, Bankiewicz KS, Christine CW, et al. Data-driven evolution of neurosurgical gene therapy delivery in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2020 Nov;91(11):1210-8.სრული ტექსტი  აბსტრაქტი

186. Christine CW, Richardson RM, Van Laar AD, et al. Safety of AADC gene therapy for moderately advanced Parkinson disease: three-year outcomes from the PD-1101 Trial. Neurology. 2022 Jan 4;98(1):e40-50.სრული ტექსტი  აბსტრაქტი

187. Jankovic J, Goodman I, Safirstein B, et al. Safety and tolerability of multiple ascending doses of PRX002/RG7935, an anti-alpha-synuclein monoclonal antibody, in patients with Parkinson disease: a randomized clinical trial. JAMA Neurol. 2018 Oct 1;75(10):1206-14.სრული ტექსტი  აბსტრაქტი

188. Pagano G, Boess FG, Taylor KI, et al; PASADENA Investigators; Prasinezumab Study Group. A phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson's disease (PASADENA): rationale, design, and baseline data. Front Neurol. 2021 Oct 1;12:705407.სრული ტექსტი  აბსტრაქტი

189. Lang AE, Siderowf AD, Macklin EA, et al; SPARK Investigators. Trial of cinpanemab in early Parkinson's disease. N Engl J Med. 2022 Aug 4;387(5):408-20. აბსტრაქტი

190. Pagano G, Taylor KI, Anzures-Cabrera J, et al; PASADENA Investigators; Prasinezumab Study Group. Trial of prasinezumab in early-stage Parkinson's disease. N Engl J Med. 2022 Aug 4;387(5):421-32. აბსტრაქტი

191. Tison F, Keywood C, Wakefield M, et al. A phase 2A trial of the novel mGluR5-negative allosteric modulator dipraglurant for levodopa-induced dyskinesia in Parkinson's disease. Mov Disord. 2016 Sep;31(9):1373-80. აბსტრაქტი

192. Addex Therapeutics. Dipraglurant-IR for PD-LID. 2022 [internet publication].სრული ტექსტი

193. ClinicalTrials.gov. PROSEEK: a phase 2 study in early Parkinson's disease patients evaluating the safety and efficacy of abl tyrosine kinase inhibition using K0706. NCT03655236. Nov 2022 [internet publication].სრული ტექსტი

194. ClinicalTrials.gov. Study in Parkinson disease of exercise (SPARX3). NCT04284436. Oct 2022 [internet publication].სრული ტექსტი

195. Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord. 2008 Apr 30;23(6):837-44.სრული ტექსტი  აბსტრაქტი

196. Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol. 2001 Oct;58(10):1611-5.სრული ტექსტი  აბსტრაქტი

197. Marras C, McDermott MP, Marek K, et al. Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts. Mov Disord. 2011 Mar;26(4):608-13. აბსტრაქტი

198. Velseboer DC, Broeders M, Post B, et al. Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PD. Neurology. 2013 Feb 12;80(7):627-33. აბსტრაქტი

199. Kelberman MA, Vazey EM. New pharmacological approaches to treating non-motor symptoms of Parkinson's disease. Curr Pharmacol Rep. 2016 Dec;2(6):253-61.სრული ტექსტი  აბსტრაქტი

200. Severiano E Sousa C, Alarcão J, Pavão Martins I, et al. Frequency of dementia in Parkinson's disease: a systematic review and meta-analysis. J Neurol Sci. 2022 Jan 15;432:120077. აბსტრაქტი

201. Wilby KJ, Johnson EG, Johnson HE, et al. Evidence-based review of pharmacotherapy used for Parkinson's disease psychosis. Ann Pharmacother. 2017 Aug;51(8):682-95. აბსტრაქტი

202. Eng ML, Welty TE. Management of hallucinations and psychosis in Parkinson's disease. Am J Geriatr Pharmacother. 2010 Aug;8(4):316-30. აბსტრაქტი

203. Iketani R, Furushima D, Imai S, et al. Efficacy and safety of atypical antipsychotics for psychosis in Parkinson's disease: a systematic review and Bayesian network meta-analysis. Parkinsonism Relat Disord. 2020 Sep;78:82-90. აბსტრაქტი

204. Cummings J, Isaacson S, Mills R, et al. Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet. 2014 Feb 8;383(9916):533-40. აბსტრაქტი

205. Espay AJ, Guskey MT, Norton JC, et al. Pimavanserin for Parkinson's Disease psychosis: effects stratified by baseline cognition and use of cognitive-enhancing medications. Mov Disord. 2018 Nov;33(11):1769-76.სრული ტექსტი  აბსტრაქტი

206. Liu B, Luo W, Mo Y, et al. Meta-analysis of related factors of impulse control disorders in patients with Parkinson's disease. Neurosci Lett. 2019 Aug 10;707:134313. აბსტრაქტი

207. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010 May;67(5):589-95.სრული ტექსტი  აბსტრაქტი

208. Corvol JC, Artaud F, Cormier-Dequaire F, et al; DIGPD Study Group. Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology. 2018 Jul 17;91(3):e189-201.სრული ტექსტი  აბსტრაქტი

209. Stocchi F, Torti M. Constipation in Parkinson's disease. Int Rev Neurobiol. 2017 Jul 13;134:811-26. აბსტრაქტი

210. Sakakibara R, Kishi M, Ogawa E, et al. Bladder, bowel, and sexual dysfunction in Parkinson's disease. Parkinsons Dis. 2011 Sep 12;2011:924605.სრული ტექსტი  აბსტრაქტი

211. Sakakibara R, Panicker J, Finazzi-Agro E, et al. A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders. Neurourol Urodyn. 2016 Jun;35(5):551-63. აბსტრაქტი

212. Hajebrahimi S, Chapple CR, Pashazadeh F, et al. Management of neurogenic bladder in patients with Parkinson's disease: a systematic review. Neurourol Urodyn. 2019 Jan;38(1):31-62. აბსტრაქტი

213. Hauser RA, Heritier S, Rowse GJ, et al. Droxidopa and reduced falls in a trial of Parkinson disease patients with neurogenic orthostatic hypotension. Clin Neuropharmacol. 2016 Sep-Oct;39(5):220-6.სრული ტექსტი  აბსტრაქტი

214. Shibao C, Lipsitz LA, Biaggioni I, et al. Evaluation and treatment of orthostatic hypotension. J Am Soc Hypertens. 2013 Jul-Aug;7(4):317-24. აბსტრაქტი

215. Isaacson SH, Skettini J. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa. Vasc Health Risk Manag. 2014 Apr 3;10:169-76.სრული ტექსტი  აბსტრაქტი

216. Wallace DM, Wohlgemuth WK, Trotti LM, et al. Practical evaluation and management of insomnia in Parkinson's disease: a review. Mov Disord Clin Pract. 2020 Apr;7(3):250-66.სრული ტექსტი  აბსტრაქტი

217. Maski K, Trotti LM, Kotagal S, et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021 Sep 1;17(9):1881-93.სრული ტექსტი  აბსტრაქტი

218. Howell M, Avidan AY, Foldvary-Schaefer N, et al. Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2023 Apr 1;19(4):759-68.სრული ტექსტი  აბსტრაქტი